RxDoctor Payments DataLook up a doctor →

Tai-Chi Kwok, MD

Geriatric Medicine · Wooster, OHNPI 1407964315

Payments from drug & device makers

$25,586in general payments, 2019–2025

Across 1,821 payments — averaging $14.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Lilly USA, LLC$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Johnson & Johnson$1K
  • Pfizer$1K
  • plus $15K from 52 others

What the payments were for

  • Food & beverage$25,552100%
  • Education$340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)99$2,745
Lilly USA, LLC171$2,040
AbbVie(2 entities)168$1,819
Novo Nordisk149$1,450
Johnson & Johnson113$1,390
Pfizer147$1,371
Bayer133$1,352
Sanofi-aventis U.S. LLC71$1,235
Merck80$1,208
Novartis82$1,055
Corcept Therapeutics60$1,034
Boehringer Ingelheim58$950
Eisai Inc.42$696
GSK45$674
Amarin Pharma, Inc.44$643
Amgen(2 entities)34$542
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC32$515
Otsuka America Pharmaceutical, Inc.34$513
Phathom Pharmaceuticals, Inc.20$507
E.r. Squibb & Sons, L.L.C.51$351
Sumitomo Pharma America, Inc.12$301
Kowa Pharmaceuticals America, Inc.20$298
Xeris Pharmaceuticals, Inc.11$195
Lundbeck LLC10$188
Esperion Therapeutics, Inc.6$162
Aurinia Pharma U.S., Inc.11$159
Radius Health, Inc.8$145
Dexcom, Inc.7$144
Boston Scientific3$142
Sanofi3$139
Astellas Pharma US Inc13$139
Exact Sciences7$129
Takeda Pharmaceuticals U.S.A., Inc.10$124
Fresenius USA Marketing, Inc.6$100
Biogen6$98
Mallinckrodt Hospital Products Inc.6$88
Urovant Sciences Inc3$79
Seqirus USA Inc4$79
Ironwood Pharmaceuticals, Inc5$79
Calliditas Therapeutics US Inc.4$75
Genentech USA, Inc.4$70
Neurocrine Biosciences, Inc.4$65
Ascendis Pharma Endocrinology Inc2$55
Aimmune Therapeutics, Inc.2$54
Ardelyx, Inc.3$52
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$41
Avanir Pharmaceuticals, Inc.3$40
Abiomed1$33
Mylan Specialty L.p.1$32
Shield Therapeutics Inc2$31
Teva Pharmaceuticals USA, Inc.1$30
OPKO Pharmaceuticals, LLC2$28
Abbott1$27
Kyowa Kirin, Inc.1$18
Amneal Pharmaceuticals LLC1$15
Currax Pharmaceuticals LLC1$15
Tactile Systems Technology Inc1$14
Medtronic1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,586 in reported general payments places this provider in the 90th percentile of 146 geriatric medicine providers in Ohio.

See all geriatric medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$302,571
Medicare patients
499
Services billed
20,683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KorlymMifepristone37$1,483,105
EliquisApixaban248$218,889
OzempicSemaglutide78$124,955
XareltoRivaroxaban80$105,230
EntrestoSacubitril/Valsartan64$73,781
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$71,565
TrulicityDulaglutide49$65,979
JardianceEmpagliflozin62$61,183
RybelsusSemaglutide45$59,972
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog52$49,936
LinzessLinaclotide51$44,102
FarxigaDapagliflozin Propanediol45$35,197
MounjaroTirzepatide29$34,767
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$29,363
JanumetSitagliptin Phos/Metformin Hcl30$22,852

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Corcept TherapeuticsKorlym$1,034$1,483,10537 claims
PfizerEliquis, Paxlovid$1,371$223,177296 claims
Novo NordiskOzempic, Rybelsus$1,450$184,927123 claims
Johnson & JohnsonXarelto$1,390$105,23080 claims
Lilly USA, LLCTrulicity, Mounjaro$2,040$100,74678 claims
Boehringer IngelheimJardiance, Tradjenta$950$80,15583 claims
NovartisEntresto$1,055$73,78164 claims
GSKTrelegy Ellipta$674$71,56561 claims
AstraZenecaFarxiga, Breztri Aerosphere$2,745$64,56067 claims
AbbVieLinzess$1,819$44,10251 claims
MerckJanumet, Verquvo$1,208$34,84941 claims
BayerKerendia$1,352$19,24711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 146 geriatric medicine providers in Ohio.

Other geriatric medicine in Wooster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →